Title : Biosimilar infliximab administration for the management of acute graft-versus-host disease.

Pub. Date : 2020 Dec

PMID : 32356680






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tumor necrosis factor (TNF) is an important cytokine involved in the pathogenesis of GVHD, and medications such as infliximab (Remicade ) have been utilized as second-line treatment options in patients with steroid-refractory GHVD. Steroids tumor necrosis factor Homo sapiens
2 Tumor necrosis factor (TNF) is an important cytokine involved in the pathogenesis of GVHD, and medications such as infliximab (Remicade ) have been utilized as second-line treatment options in patients with steroid-refractory GHVD. Steroids tumor necrosis factor Homo sapiens
3 Although we had important limitations, this case report supports the use of anti-TNF agents in highly mortal steroid-refractory acute GI GVHD and that replacement of infliximab with its biosimilars is feasible. Steroids tumor necrosis factor Homo sapiens